According to the American Cancer Society, colorectal cancer is the second leading cause of cancer death. Enrichment of regulatory T cells (T-regs) in solid cancers is generally associated with poor ...

AI could "give the scientific community a way to address the most difficult and urgent questions in human health," argues ...

A long-standing mystery in cancer treatment is how tumor cells so often become resistant to drugs, even ones they have never encountered before.

A Moffitt Cancer Center researcher has introduced a new model that addresses one of biology's most fundamental questions: How does genetic information keep living systems organized and therefore alive ...

A newly proposed model suggests cancer cells may resist treatment not just through genetic mutations, but by dynamically ...

Researchers engineered a panel of drug-resistant NSCLC models using CRISPR gene editing and gene overexpression techniques.

Loss of an enzyme necessary for a process called lipoylation disrupts the way cancer cells copy their DNA, increasing their ...

New research has identified a protein that could serve as both a biomarker and therapeutic target to weaken stem-like cancer ...

Technion researchers part of international study that validates fast, accessible alternative to genomic tests using routine pathology samples.

Scientists at The Wistar Institute and clinical researchers from ChristianaCare's Helen F. Graham Cancer Center & Research ...